These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17603267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients.
    Masuda S, Inui K.
    Pharmacol Ther; 2006 Oct; 112(1):184-98. PubMed ID: 16759707
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors.
    Utecht KN, Hiles JJ, Kolesar J.
    Am J Health Syst Pharm; 2006 Dec 01; 63(23):2340-8. PubMed ID: 17106006
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
    Steinebrunner N, Sandig C, Sommerer C, Hinz U, Giese T, Stremmel W, Zahn A.
    Ann Transplant; 2014 Jan 22; 19():32-40. PubMed ID: 24457606
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M, Yano I, Masuda S, Fukatsu S, Katsura T, Ogura Y, Oike F, Takada Y, Tanaka K, Inui K.
    Clin Pharmacol Ther; 2005 Aug 22; 78(2):168-81. PubMed ID: 16084851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE, Goodman LK, Tett SE.
    Clin Pharmacokinet; 2010 Apr 22; 49(4):207-21. PubMed ID: 20214406
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
    Staatz CE, Tett SE.
    Clin Pharmacokinet; 2004 Apr 22; 43(10):623-53. PubMed ID: 15244495
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child.
    Zhao W, Baudouin V, Fakhoury M, Storme T, Deschênes G, Jacqz-Aigrain E.
    Transplantation; 2012 Apr 15; 93(7):e29-30. PubMed ID: 22450597
    [No Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
    Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Inui K.
    Clin Pharmacol Ther; 2006 Oct 15; 80(4):331-45. PubMed ID: 17015051
    [Abstract] [Full Text] [Related]

  • 20. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients.
    Masuda S, Goto M, Okuda M, Ogura Y, Oike F, Kiuchi T, Tanaka K, Inui K.
    Transplant Proc; 2005 May 15; 37(4):1728-9. PubMed ID: 15919446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.